{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:16:46Z","timestamp":1789514206626,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1124\/jpet.121.000828","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T22:20:21Z","timestamp":1637274021000},"page":"114-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors"],"prefix":"10.1016","volume":"380","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5311-1917","authenticated-orcid":false,"given":"Chitra","family":"Saran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Sundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonna","family":"Niskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4332-3577","authenticated-orcid":false,"given":"Paavo","family":"Honkakoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1945-4929","authenticated-orcid":false,"given":"Kim L.R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.121.000828_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/toxsci\/kfn268","article-title":"Bile acid sulfation: a pathway of bile acid elimination and detoxification","volume":"108","author":"Alnouti","year":"2009","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.121.000828_bib3","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.121.000828_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12185-015-1788-y","article-title":"Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia","volume":"102","author":"Ando","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1124\/jpet.121.000828_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.20090","article-title":"Cellular regulation of hepatic bile acid transport in health and cholestasis","volume":"39","author":"Anwer","year":"2004","journal-title":"Hepatology"},{"key":"10.1124\/jpet.121.000828_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107542","article-title":"Novel insights into the organic solute transporter alpha\/beta, OST\u03b1\/\u03b2: From the bench to the bedside","volume":"211","author":"Beaudoin","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.121.000828_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","article-title":"Kinase-targeted cancer therapies: progress, challenges and future directions","volume":"17","author":"Bhullar","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1124\/jpet.121.000828_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/clpt.2013.81","article-title":"In vitro methods to support transporter evaluation in drug discovery and development","volume":"94","author":"Brouwer","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.121.000828_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cld.2016.08.009","article-title":"Drug hepatotoxicity: newer agents","volume":"21","author":"Bunchorntavakul","year":"2017","journal-title":"Clin Liver Dis"},{"key":"10.1124\/jpet.121.000828_bib10","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1038\/s41467-018-04697-5","article-title":"Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis","volume":"9","author":"Byun","year":"2018","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.121.000828_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","article-title":"Hepatocyte-based in vitro model for assessment of drug-induced cholestasis","volume":"274","author":"Chatterjee","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.121.000828_bib12","doi-asserted-by":"crossref","first-page":"d176","DOI":"10.2741\/A273","article-title":"Regulation of bile acid synthesis","volume":"3","author":"Chiang","year":"1998","journal-title":"Front Biosci"},{"key":"10.1124\/jpet.121.000828_bib13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cphy.c120023","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1124\/jpet.121.000828_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/clpt.2013.78","article-title":"Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver","volume":"94","author":"Chu","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.121.000828_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1124\/dmd.118.080663","article-title":"Beyond competitive inhibition: Regulation of ABC transporters by kinases and protein\u2013protein interactions as potential mechanisms of drug\u2013drug interactions","volume":"46","author":"Crawford","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.121.000828_bib16","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.121.000828_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.121.000828_bib18","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1074\/jbc.273.16.10046","article-title":"The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver","volume":"273","author":"Gerloff","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.121.000828_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.121.000828_bib20","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI117091","article-title":"Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+\/bile acid cotransporter","volume":"93","author":"Hagenbuch","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.121.000828_bib21","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1158\/1078-0432.CCR-21-0023","article-title":"Regulation of OATP1B1 function by tyrosine kinase-mediated phosphorylation","volume":"27","author":"Hayden","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.121.000828_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3470321","article-title":"Regulation of cytochrome P450 (CYP) genes by nuclear receptors","volume":"347","author":"Honkakoski","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/jpet.121.000828_bib23","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1158\/1078-0432.CCR-09-0048","article-title":"Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters","volume":"15","author":"Hu","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.121.000828_bib24","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/bjc.2013.811","article-title":"Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro\u2013in vivo correlations","volume":"110","author":"Hu","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1124\/jpet.121.000828_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4939-9420-5_5","article-title":"The C-DILI\u2122 assay: An integrated in vitro approach to predict cholestatic hepatotoxicity","volume":"1981","author":"Jackson","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1124\/jpet.121.000828_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/aivt.2016.0023","article-title":"Basolateral efflux transporters: A potentially important pathway for the prevention of cholestatic hepatotoxicity","volume":"2","author":"Jackson","year":"2016","journal-title":"Appl In Vitro Toxicol"},{"key":"10.1124\/jpet.121.000828_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/aivt.2018.0011","article-title":"Cholestatic drug induced liver injury: A function of bile salt export pump inhibition and farnesoid X receptor antagonism","volume":"4","author":"Jackson","year":"2018","journal-title":"Appl In Vitro Toxicol"},{"key":"10.1124\/jpet.121.000828_bib28","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3390\/ijms19082367","article-title":"Role of cytochrome P450 enzymes in the metabolic activation of tyrosine kinase inhibitors","volume":"19","author":"Jackson","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.121.000828_bib29","doi-asserted-by":"crossref","first-page":"8190","DOI":"10.1016\/S0021-9258(19)39056-8","article-title":"Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis","volume":"265","author":"Jelinek","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.121.000828_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1124\/jpet.121.000828_bib31","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/cpt.1222","article-title":"Can bile salt export pump inhibition testing in drug discovery and development reduce liver injury risk? An international transporter consortium perspective","volume":"104","author":"Kenna","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.121.000828_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-642-14541-4_8","article-title":"Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy","volume":"201","author":"Keppler","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/jpet.121.000828_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/dmd.113.054304","article-title":"Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4","volume":"42","author":"K\u00f6ck","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.121.000828_bib34","first-page":"G12","article-title":"Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration","volume":"277","author":"Liu","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.121.000828_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fcell.2020.00095","article-title":"Dissecting the role of the FGF19-FGFR4 signaling pathway in cancer development and progression","volume":"8","author":"Liu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1124\/jpet.121.000828_bib36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/jpet.121.000828_bib37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","article-title":"Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors","volume":"6","author":"Lu","year":"2000","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.121.000828_bib38","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1124\/dmd.115.067629","article-title":"Hepatocellular disposition and transporter interactions with tolvaptan and metabolites in sandwich-cultured human hepatocytes","volume":"44","author":"Lu","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.121.000828_bib39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.121.000828_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxsci\/kft176","article-title":"A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development","volume":"136","author":"Morgan","year":"2013","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.121.000828_bib41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cpt.564","article-title":"Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management","volume":"101","author":"Mosedale","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.121.000828_bib42","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1053\/gast.2002.36587","article-title":"Functional expression of the canalicular bile salt export pump of human liver","volume":"123","author":"No\u00e9","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.121.000828_bib43","doi-asserted-by":"crossref","first-page":"34237","DOI":"10.1074\/jbc.M300987200","article-title":"The human bile acid-CoA:amino acid N-acyltransferase functions in the conjugation of fatty acids to glycine","volume":"278","author":"O\u2019Byrne","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.121.000828_bib44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2011.11.032","article-title":"Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes","volume":"416","author":"Ogimura","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.121.000828_bib45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tiv.2016.03.008","article-title":"Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes","volume":"34","author":"Oorts","year":"2016","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/jpet.121.000828_bib46","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.xphs.2017.03.022","article-title":"Pretreatment with rifampicin and tyrosine kinase inhibitor dasatinib potentiates the inhibitory effects toward OATP1B1- and OATP1B3-mediated transport","volume":"106","author":"Pahwa","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.121.000828_bib47","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/toxsci\/kfs011","article-title":"Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys","volume":"126","author":"Pai","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.121.000828_bib48","doi-asserted-by":"crossref","first-page":"G878","DOI":"10.1152\/ajpgi.2001.281.4.G878","article-title":"Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasis","volume":"281","author":"Pandak","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.121.000828_bib49","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/toxsci\/kft197","article-title":"Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP\/ABCB11)","volume":"136","author":"Pedersen","year":"2013","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.121.000828_bib1","unstructured":"Qualyst Transporter Solutions Technical Application Bulletin (2011) TAB Biol 005v2."},{"key":"10.1124\/jpet.121.000828_bib50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1124\/dmd.117.079152","article-title":"Comparison of species and cell-type differences in fraction unbound of liver tissues, hepatocytes, and cell lines","volume":"46","author":"Riccardi","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.121.000828_bib51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40264-013-0048-4","article-title":"Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives","volume":"36","author":"Shah","year":"2013","journal-title":"Drug Saf"},{"key":"10.1124\/jpet.121.000828_bib52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"key":"10.1124\/jpet.121.000828_bib53","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1124\/dmd.112.048181","article-title":"Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites","volume":"41","author":"Swift","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.121.000828_bib54","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/03602530903491881","article-title":"Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity","volume":"42","author":"Swift","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1124\/jpet.121.000828_bib55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nm815","article-title":"The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4","volume":"9","author":"Tirona","year":"2003","journal-title":"Nat Med"},{"key":"10.1124\/jpet.121.000828_bib56","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/tra.12354","article-title":"The Na(+)-taurocholate cotransporting polypeptide traffics with the epidermal growth factor receptor","volume":"17","author":"Wang","year":"2016","journal-title":"Traffic"},{"key":"10.1124\/jpet.121.000828_bib57","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1158\/1535-7163.MCT-18-1291","article-title":"FGF401, a first-in-class highly selective and potent FGFR4 inhibitor for the treatment of FGF19-driven hepatocellular cancer","volume":"18","author":"Weiss","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.121.000828_bib58","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/pr500920q","article-title":"Profiling of serum bile acids in a healthy Chinese population using UPLC-MS\/MS","volume":"14","author":"Xie","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1124\/jpet.121.000828_bib59","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s00204-016-1918-1","article-title":"Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria","volume":"91","author":"Zhang","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1124\/jpet.121.000828_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1476-5381.2008.00030.x","article-title":"Nuclear receptors as therapeutic targets in cholestatic liver diseases","volume":"156","author":"Zollner","year":"2009","journal-title":"Br J Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.000828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:25:43Z","timestamp":1739971543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524002325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0022356524002325"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.000828","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.000828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}